SOX12 and neoplasm: However, the combination treatment of C‐021 and anti‐PD‐L1 dramatically inhibited these SOX12‐mediated tumor‐promoting roles compared with the two single‐drug groups (Figure7A–E; Figure S15A–D, Supporting Information).